Comparison of the Immune Responses to COVID-19 Vaccines in Bangladeshi Population
Authors:
- Protim SarkerPSProtim Sarker
- Evana AkhtarEAEvana Akhtar
- Rakib Ullah KuddusiRKRakib Ullah Kuddusi
- Mohammed Mamun AlamMAMohammed Mamun Alam
- Ahsanul HaqAHAhsanul Haq
- Biplob HosenBHBiplob Hosen
- Bikash Chandra ChandaBCBikash Chandra Chanda
- Farjana HaqueFHFarjana Haque
- Muntasir AlamMuntasir Alam
- Abdur RazzaqueARAbdur Razzaque
- Mustafizur RahmanMRMustafizur Rahman
- Faruque AhmedFAFaruque Ahmed
Open Access
Abstract
Background: The adaptive immune response is a crucial component of the protective immunity against SARS-CoV-2, generated after infection or vaccination. Methods: We studied antibody titers, neutralizing antibodies and cellular immune responses to four different COVID-19 vaccines, namely Pfizer-BioNTech, Moderna Spikevax, AstraZeneca and Sinopharm vaccines in the Bangladeshi population (n = 1780). Results: mRNA vaccines Moderna (14,655 ± 11.3) and Pfizer (13,772 ± 11.5) elicited significantly higher anti-Spike (S) antibody titers compared to the Adenovector vaccine AstraZeneca (2443 ± 12.8) and inactivated vaccine Sinopharm (1150 ± 11.2). SARS-CoV-2-specific neutralizing antibodies as well as IFN-γ-secreting lymphocytes were more abundant in Pfizer and Moderna vaccine recipients compared to AstraZeneca and Sinopharm vaccine recipients. Participants previously infected with SARS-CoV-2 exhibited higher post-vaccine immune responses (S-specific and neutralizing antibodies, IFN-γ-secreting cells) compared to uninfected participants. Memory B (BMEM), total CD8+T, CD4+ central memory (CD4+CM) and T-regulatory (TREG) cells were more numerous in AstraZeneca vaccine recipients compared to other vaccine recipients. Plasmablasts, B-regulatory (BREG) and CD4+ effector (CD4+EFF) cells were more numerous in mRNA vaccine recipients. Conclusions: mRNA vaccines generated a higher antibody response, while a differential cellular response was observed for different vaccine types, suggesting that both cellular and humoral responses are important in immune monitoring of different types of vaccines.Keywords
Funding Information
- The Foreign, Commonwealth & Development Office (FCDO; GR-02142)
- The United Nations Children’s Fund (UNICEF; GR-02141)
- Institute of Development Studies (IDS; GR-02144)
This publication has 54 references indexed in Scilit:
- Regulatory T Cells Suppress Effector T Cell Proliferation by Limiting Division DestinyFrontiers in Immunology, 2018
- The role of regulatory T cells in immunopathogenesis and immunotherapy of viral infectionsInfection, Genetics and Evolution, 2018
- Regulatory B Cells: Origin, Phenotype, and FunctionImmunity, 2015
- CD8 T Cells Use IFN-γ To Protect against the Lethal Effects of a Respiratory Poxvirus InfectionThe Journal of Immunology, 2014
- Persistence of Transgene Expression Influences CD8+T-Cell Expansion and Maintenance following Immunization with Recombinant AdenovirusJournal of Virology, 2009
- Role of regulatory T cells in coronavirus-induced acute encephalitisVirology, 2009
- Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccinesBlood, 2007
- Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunityProceedings of the National Academy of Sciences, 2004
- Central Memory and Effector Memory T Cell Subsets: Function, Generation, and MaintenanceAnnual Review of Immunology, 2004
- The antiviral activity of immune CD8+ T cells is dependent on interferon-gamma.1991